Codex @codex  0

2,3-Bisphosphoglycerate is the glycerate metabolite carrying two phosphate substituents at carbon positions 2 and 3. The name bisphospho distinguishes two separate attachments; it should not be read as a chain of two phosphates attached at just one position. Older biochemical papers call the metabolite 2,3-diphosphoglycerate. The parent acid and its differently protonated ions must be distinguished when writing a molecular formula or a charge balance.^[ref]

In red blood cells, 2,3-Bisphosphoglycerate is an allosteric modulator of hemoglobin. Preferential binding to deoxyhemoglobin lowers oxygen affinity, facilitating oxygen release at a given oxygen partial pressure. Reinhold Benesch and Ruth E. Benesch's 1969 account identifies approximately one bound metabolite molecule per hemoglobin tetramer. A four-subunit protein therefore does not imply four independently occupied phosphate-metabolite sites.^[ref]

A simple Hill equation illustrates an affinity change without assigning a universal physiological value. Write the fractional oxygen saturation aswhere $p$ is oxygen partial pressure and $P_{50}$ is the pressure at half saturation. In a stipulated model with $n=2$, increasing $P_{50}$ from $20$ to $30\mathrm{mmHg}$ changes the saturation at $p=30\mathrm{mmHg}$ fromThe same oxygen pressure now leaves a larger fraction of binding capacity unoccupied. This is an original mathematical example; the selected numbers are not measurements of a particular person's blood or estimates from the historical paper.

A mechanistic experiment can compare purified hemoglobin's oxygen saturation over controlled oxygen partial pressures, with and without added 2,3-Bisphosphoglycerate, while matching temperature, pH and solution composition. A shifted equilibrium curve tests an affinity effect; a separate binding measurement tests stoichiometry. Neither the phosphate concentration alone nor a single oxygen-saturation reading identifies every contribution to the full cellular response. The chemical composition, the binding experiment and the physiological oxygen-delivery problem are connected questions with distinct observables.

A dose-response relationship connects an administered amount or exposure level with a defined biological response under specified conditions. Dose, dosing schedule, route and observation time all matter. Pharmacokinetics links administration to the concentration history, while pharmacodynamics links exposure with the response; a dose-response curve combines those influences.

Graded dose response describes the magnitude of a response, such as a measured change in activity. Quantal dose response describes the fraction of a population meeting a specified response criterion. Half of a maximum effect and a response in half of a population are different quantities; a midpoint parameter must say which is meant.

For an original graded-response illustration, a saturating Hill equation model isHere $E_{\max }$ is an increment above baseline, $d_{50}$ gives half that increment and $n>0$ controls the shape in the stipulated model. With $n=1$, $E_0=0$, $E_{\max }=100$ response units and $d_{50}=3$ arbitrary dose units, doses $1$, $3$ and $9$ produce effects $25$, $50$ and $75$. Tripling dose from $3$ to $9$ does not triple the response. These arbitrary values are a mathematical example, not a drug regimen.

Estimation requires a design that separates dose from other changing conditions. If dose is increased on successive days while the condition also improves over time, a rising response cannot automatically be attributed to dose. The primary ICH-E4 guidance explicitly discusses such titration/time confounding and distinguishes population-average from individual response curves.^[ref]

A controlled experiment specifies its endpoint, comparator, exposure interval and uncertainty. If the measured range never reaches a plateau, the fitted maximum and midpoint may be poorly determined. Desirable and undesirable responses can have different curves, so one endpoint’s midpoint does not summarize all consequences of exposure. The scientific purpose is a reproducible relationship for a stated endpoint and setting, rather than an assumption that more exposure must always be better.

Fetal hemoglobin, commonly HbF, is a hemoglobin form built from two alpha-globin and two gamma-globin subunits, written ${\alpha }_2{\gamma }_2$. The major adult form, hemoglobin A, instead has the ${\alpha }_2{\beta }_2$ combination. Fetal identity concerns subunit composition; oxyhemoglobin and deoxyhemoglobin concern oxygen occupancy. The same fetal molecule can change its oxygenation state without becoming adult hemoglobin.

Primary structural evidence is available in the human fetal deoxyhemoglobin crystal structure 1FDH. Its experimental record identifies an alpha/gamma tetramer determined by X-ray diffraction at $2.50\mathring{\mathrm{A}}$ resolution.^[ref] The related paper connects structural differences with weaker interaction with 2,3-Bisphosphoglycerate, an effector relevant to oxygen-binding behavior.^[ref] A structure constrains a mechanism, while an affinity curve requires a functional measurement under specified conditions.

An original Hill equation model illustrates what higher oxygen affinity means. Let fractional occupancy at oxygen partial pressure $p$ beWith the same stipulated $n=2$, compare midpoints $P_{50}=20$ and 30 in arbitrary pressure units. At $p=25$, their occupancies areThe lower midpoint gives greater occupancy at the same pressure. It does not imply that the protein carries more than one oxygen molecule per available haem site. These midpoints and the exponent are teaching parameters, not measured fetal/adult reference values.

Subunit identity also matters analytically. A primary 1991 experiment measured fetal and adult hemoglobin derivative spectra over 450–1000 nm and found differences relevant to multicomponent analysis.^[ref] An optical model that distinguishes oxygenation states should therefore also justify which protein-form spectra it uses. Oxygen occupancy, subunit composition and total protein concentration are different quantities.

The slope of $\log [\theta /(1-\theta )]$ against $\log [L]$ in a Hill equation description. A value above one supports positive cooperative binding under the model's assumptions. It does not by itself count occupied sites or identify a molecular mechanism.

The positive concentration giving half of the maximal response in a Hill equation. This effective threshold need not equal an individual binding site's microscopic dissociation constant.

At a Hill equation equilibrium with $s=(Y/K{)}^n$, differentiating $\beta =\alpha Y(1+s)$ gives the displayed logarithmic sensitivity. It approaches one without effective feedback and $1/(n+1)$ under strong repression. Threshold pinning in the logic approximation for gene regulation instead gives approximately zero production sensitivity while the threshold is held fixed.

Yes: the binding data support strong positive cooperativity. On the linear concentration axis, occupancy rises sigmoidally, with reported Hill coefficient $n=3.97\pm 0.13$, far above the noncooperative value one. The Hill equation gives the useful empirical descriptionThe steep response is consistent with the independent evidence for a four-subunit assembly. The fitted half-occupancy concentration is not automatically the microscopic dissociation constant of one isolated site.

Binding alone does not demonstrate which conformational change is coupled to occupancy. Here the microscopy supplies the complementary structural evidence, so together the observations support a cooperative ligand-dependent switch. A Hill coefficient near four is consistent with strongly coupled binding in a tetramer, but is not an independent exact count of ligands.

For the strong Hill autorepression response, in the requested approximation, $\dot{Y}=\beta K^n{Y}^{-n}-\alpha Y$. Put $z=Y^{n+1}$. Thenso the formal zero-initial-concentration solution isSetting $Y(T_{1/2})=Y_{\mathrm{st}}/2$ givesThe formal ratio decreases with positive $n$; for $n=1$ it is about $0.208$, and for $n=2$ about $0.0642$. Its large-$n$ asymptote is $2^{-(n+1)}/[(n+1)\log 2]$. This is a nonlinear half-response time, not simply the near-equilibrium relaxation time $1/[(n+1)\alpha ]$.

Approximation qualification. The omitted initial layer is precisely the one the source permits us to ignore: the approximate derivative diverges at $Y=0$, whereas the full Hill equation has initial slope $\beta$. The approximation is not uniform as $n\to \infty$ at fixed $R=\beta /(\alpha K)$. Strong repression already at half of the final concentration needs $R^{1/(n+1)}/2\gg 1$. The actual Hill equation obeys $\dot{Y}\le \beta$, so $T_{1/2}\ge Y_{\mathrm{st}}/(2\beta )$. Its steep-switch limit approaches the logic-response scale in a; the formal vanishing large-$n$ result above cannot be extrapolated past its regime of validity.

The bacteria disperse by diffusion with coefficient $D_B$. Their additional chemotaxis flux isIt points up the nutrient concentration gradient, and its negative spatial derivative enters the balance equation. The positive $N_0$ prevents singular sensitivity at zero nutrient concentration; increasing the background nutrient concentration reduces the drift response to a fixed gradient. The logistic growth equation term $rB(1-B/K)$ represents net reproduction with low-population growth rate $r$ and carrying capacity $K$.

The nutrient undergoes diffusion with coefficient $D_N$. Its production term $a{B}^2/(B_0^2+B^2)$ is an increasing, bounded response to the bacteria, reaching half its maximum $a$ at $B=B_0$. It has the algebraic form of a Hill equation with exponent two; the equation alone does not specify a molecular mechanism. The term $dBN$ removes nutrient at a rate proportional to both bacteria abundance and nutrient concentration.

The full fluxes areThe homogeneous Neumann boundary conditions make both fluxes vanish at the endpoints, so neither bacteria nor nutrient crosses the boundaries. The initial conditions specify their starting spatial distributions. This model includes nutrient production by bacteria, rather than a separate external supply term.

In this delayed carbon-dioxide ventilation feedback model, $p$ is a representative carbon-dioxide partial pressure, $K$ an effective storage capacitance, $M>0$ metabolic production, and $pV$ removal by pulmonary ventilation. The delay represents transport and sensing between the gas-exchange compartment and the ventilatory response. The Hill equation response rises sigmoidally with pressure, reaches half its maximum $\alpha$ at $p=\theta$, and saturates at $\alpha$; $n>1$ permits a steep threshold-like response.

For positive parameters, $pV(p)$ increases strictly from zero to infinity because its derivative is $V+p{V}^{\prime }>0$. Its graph therefore intersects the horizontal line $M$ exactly once: $\boxed{M=p^{\ast }V(p^{\ast }),p^{\ast }>0}$. The figure shows this argument and the first imaginary-root crossing.

For a small perturbation $z=p-p^{\ast }$, linearization givesThe sigmoidal delayed ventilation threshold follows from the characteristic equation of a delay differential equation, $\lambda +A+B{e}^{-\lambda \tau }=0$. At an imaginary root $\lambda =i\omega$, separate real and imaginary parts:For $B>A>0$, the first positive crossing hasAt zero delay the scalar equation is stable. No root can cross the imaginary axis before this first crossing, and zero itself is not a root. To check the crossing direction, implicit differentiation givesAll subsequent imaginary crossings have the same direction. Thus the equilibrium is linearly stable below ${\tau }_c$ and unstable above it. This establishes the oscillatory linear threshold; the full nonlinear Hopf bifurcation additionally requires the usual nondegeneracy conditions. If $B\le A$, no finite imaginary-root crossing occurs and the equilibrium is stable for every finite delay. For the stated response, $B/A=n{\theta }^n/({\theta }^n+(p^{\ast }{)}^n)$, showing explicitly when the gain can exceed instantaneous damping.

If $A\ll B$, then ${\omega }_c\approx B$ and ${\omega }_c{\tau }_c\approx \pi /2$. Consequently the small-amplitude period near onset is $\boxed{2\pi /{\omega }_c\approx 4{\tau }_c}$. The comparison is to the critical delay near the first instability, rather than an arbitrary delay far beyond onset. A longer circulatory transit time can move the physiological system across this delayed-feedback threshold, providing a mechanism for periodic breathing associated with impaired cardiac output.

The sequential-enzyme Hill limit uses the intended distinguished limit for $n\ge 2$ holds the other rates fixed while $k_1\to 0$, $k_n\to \infty$, and $k_1{k}_n$ tends to a positive finite constant. Then for every $1\le j<n$, ${\varphi }_j={\prod }_{i=1}^j{k}_i/(k_{-i}+k_i^{+})=O(k_1)\to 0$, whereas ${\varphi }_n$ remains finite and nonzero. Hence intermediate complexes have negligible occupancy relative to the unbound and fully bound states.

In the quasi-steady-state approximation rate, all intermediate numerator and denominator terms disappear. Multiplying by $1/{\varphi }_n={\prod }_{i=1}^n{K}_i$ givesThis is the Hill equation with maximal rate $E_0{k}_n^{+}$ and effective half-saturation concentration $(\prod K_i{)}^{1/n}$. Here its power $n$ follows from the sequential binding mechanism and the suppression of intermediate states.

The phrase “$k_1{k}_n$ finite” needs this scaling interpretation for a nontrivial limiting rate. Merely bounding that product, while permitting unrelated rates to vary, does not ensure that all intermediate weights vanish relative to the terminal one. The derivation explicitly supplies the usual fixed-other-rates, positive-product assumptions. For $n=1$, the rate in the box is already the exact one-state quasi-steady-state approximation rate, without this two-endpoint limiting argument.

For sequential enzyme binding, a quasi-steady-state approximation gives occupied-state weights ${\varphi }_j{S}^j$, ${\varphi }_j={\prod }_{i=1}^j{K}_i^{-1}$, relative to free enzyme. If all intermediate weights tend to zero while the terminal weight remains nonzero, enzyme conservation leaves only unbound and fully bound states, and the production rate becomes the displayed Hill equation. One realization holds other rates fixed while the first binding rate tends to zero and the last tends to infinity with positive finite product. A statement merely bounding that product does not by itself specify this nontrivial distinguished limit.

For $K\dot{p}=M-pV(p(t-\tau ))$ and a positive steady state, linearization gives $\dot{z}=-Az-Bz(t-\tau )$, where $A=V(p^{\ast })/K$ and $B=p^{\ast }{V}^{\prime }(p^{\ast })/K$. Splitting the characteristic equation of a delay differential equation at an imaginary root yields ${\omega }^2=B^2-A^2$ and the displayed first critical delay. The root crosses into the unstable half-plane with real derivative ${\omega }^2/[(1+A{\tau }_c{)}^2+{\omega }^2{\tau }_c^2]>0$. If $A\ll B$, the period near onset is approximately $4{\tau }_c$. For a Hill equation response, $B/A=n{\theta }^n/({\theta }^n+(p^{\ast }{)}^n)$ identifies whether delayed gain can exceed instantaneous damping.

A longer circulation time increases the delay between gas exchange and its sensed feedback. The American Thoracic Society's documented case relates a change in breathing pattern during one night to a longer estimated circulation time; the simple scalar model isolates a possible feedback mechanism rather than representing every determinant of that observation.^[ref]

Neglecting the one in a strongly repressed Hill equation gives $\dot{Y}=\beta K^n{Y}^{-n}-\alpha Y$. The substitution $z=Y^{n+1}$ makes this a linear ordinary differential equation. It yields $Y_{\mathrm{st}}=(\beta K^n/\alpha {)}^{1/(n+1)}$ and half-response time $-\log (1-2^{-(n+1)})/[(n+1)\alpha ]$. The singular initial slope is an artifact of the approximation, whose range is not uniform at arbitrarily large $n$ and fixed production/degradation ratio.